Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Athersys (ATHX)

Athersys Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATHX
DateTimeSourceHeadlineSymbolCompany
08/01/202412:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
22/12/202322:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
21/12/202316:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
16/11/202313:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
18/10/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
16/10/202321:52Business WireAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesNASDAQ:ATHXAthersys Inc
12/10/202314:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
11/10/202314:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
10/10/202313:30Business WireAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosNASDAQ:ATHXAthersys Inc
06/10/202322:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
06/10/202322:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
03/10/202321:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
03/10/202321:30Business WireAthersys Licenses its Animal Health Assets to Ardent Animal HealthNASDAQ:ATHXAthersys Inc
02/10/202322:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
02/10/202322:04Business WireAthersys Director Jane Wasman Appointed Board ChairNASDAQ:ATHXAthersys Inc
25/09/202321:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATHXAthersys Inc
22/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATHXAthersys Inc
19/09/202317:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
19/09/202302:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATHXAthersys Inc
19/09/202302:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
14/09/202316:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
14/09/202315:41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
13/09/202322:13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ATHXAthersys Inc
11/09/202313:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
06/09/202319:45Business WireGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationNASDAQ:ATHXAthersys Inc
21/08/202319:36Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ATHXAthersys Inc
18/08/202315:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
18/08/202302:30Business WireAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingNASDAQ:ATHXAthersys Inc
17/08/202321:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATHXAthersys Inc
16/08/202322:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
 Showing the most relevant articles for your search:NASDAQ:ATHX